Home > Boards > US Listed > Medical - Drugs > Merck & Co. Inc. (MRK)

FDA approves MRK’ Herceptin biosimilar, called Ontruzant:

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
DewDiligence Member Profile
Member Level 
Followed By 739
Posts 112,984
Boards Moderated 16
Alias Born 09/05/02
160x600 placeholder
Merck Announces New Analyses Showing Additional Safety & Efficacy Data for Investigational Islatravir in Combination with Dor... Business Wire - 7/6/2020 6:45:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/2/2020 3:45:50 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/2/2020 2:46:30 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/2/2020 2:46:07 PM
Merck Animal Health Completes Acquisition of U.S. Rights to SENTINEL® Brand of Combination Parasiticides for Companion Animals Business Wire - 7/2/2020 2:00:00 AM
Merck and Ridgeback Bio Announce Closing of Collaboration and Licensing Transaction Business Wire - 7/1/2020 4:30:00 PM
Merck to Hold Second-Quarter 2020 Sales and Earnings Conference Call on July 31 Business Wire - 7/1/2020 6:45:00 AM
FDA Approves Merck’s KEYTRUDA® (pembrolizumab) for First-Line Treatment of Patients With Unresectable or Metastatic MSI-H ... Business Wire - 6/29/2020 4:20:00 PM
FDA Approves Merck’s KEYTRUDA® (pembrolizumab) for the Treatment of Patients with Recurrent or Metastatic Cutaneous Squamo... Business Wire - 6/24/2020 5:29:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/24/2020 4:21:55 PM
Merck Underscores Commitment to HIV with New Data Analyses to be Presented at AIDS 2020: Virtual Business Wire - 6/24/2020 6:45:00 AM
Annual Report of Employee Stock Plans (11-k) Edgar (US Regulatory) - 6/23/2020 2:18:55 PM
Merck Announces That V114, Its Investigational 15-valent Pneumococcal Conjugate Vaccine, Met Safety & Immunogenicity Objectiv... Business Wire - 6/22/2020 6:45:00 AM
Merck’s KEYTRUDA® (pembrolizumab) Approved in China for Second-Line Treatment of Patients with Locally Advanced or Metasta... Business Wire - 6/22/2020 6:30:00 AM
Merck Completes Acquisition of Themis Business Wire - 6/19/2020 8:29:00 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 6/18/2020 5:00:08 PM
Merck Animal Health Completes Acquisition of Quantified Ag® Business Wire - 6/17/2020 4:30:00 PM
FDA Approves Second Biomarker-Based Indication for Merck’s KEYTRUDA® (pembrolizumab), Regardless of Tumor Type Business Wire - 6/17/2020 6:45:00 AM
Merck Prices $4.5 Billion Debt Offering Business Wire - 6/17/2020 6:30:00 AM
Merck & Pfizer’s SGLT2 Inhibitor STEGLATROTM (ertugliflozin) Meets Primary Endpoint in VERTIS CV Trial for Patients with Ty... Business Wire - 6/16/2020 1:15:00 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 6/16/2020 9:05:45 AM
Merck Announces Call for Proposals for Second Cohort of Safer Childbirth Cities, Expanding Maternal Health Support Across US ... Business Wire - 6/15/2020 8:00:00 AM
FDA Approves Merck’s GARDASIL 9 for the Prevention of Certain HPV-Related Head and Neck Cancers Business Wire - 6/12/2020 6:40:00 PM
Merck Provides Update on Phase 3 KEYNOTE-361 Trial Evaluating KEYTRUDA® (pembrolizumab) as Monotherapy & in Combination with... Business Wire - 6/9/2020 4:05:00 PM
FDA Approves Merck’s RECARBRIO™ (imipenem, cilastatin, & relebactam) for the Treatment of Adults with Hospital-Acquired &... Business Wire - 6/5/2020 6:50:00 AM
DewDiligence Member Level  Wednesday, 04/15/20 09:15:49 AM
Re: None
Post # of 544 
FDA approves MRK’ Herceptin biosimilar, called Ontruzant:

https://www.businesswire.com/news/home/20200415005021/en
Quote:
Ontruzant will be introduced in the U.S. at a list price (wholesaler acquisition cost) of approximately $1,325 for the 150 mg single-dose vial and $3,709 for the 420 mg multiple-dose vial (prices are rounded), representing a 15% discount to the current list price of Herceptin. Wholesaler acquisition costs do not include discounts to payers, providers, distributors and other purchasing organizations.



“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist